Evidence map›Paper›PMID 40590226›Full record

ArticleThe Journal of clinical investigation2025

Purinergic signaling modulates CD4+ T cells with cytotoxic potential during Trypanosoma cruzi infection.

Gastón Bergero, Yanina L Mazzocco, Sebastian Del Rosso, Ruining Liu, Zoé M Cejas Gallardo, Simon C Robson, Martin Rottenberg, Maria P Aoki

Abstract read
In one paragraph

Article in The Journal of clinical investigation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Gastón BergeroUniversidad Nacional de Córdoba, Facultad de Ciencias Químicas, Departamento de Bioquímica Clínica, Córdoba, Argentina.
Yanina L MazzoccoUniversidad Nacional de Córdoba, Facultad de Ciencias Químicas, Departamento de Bioquímica Clínica, Córdoba, Argentina.
Sebastian Del RossoUniversidad Nacional de Córdoba, Facultad de Ciencias Químicas, Departamento de Bioquímica Clínica, Córdoba, Argentina.
Ruining LiuDepartment of Microbiology, Tumor and Cell Biology, Karolinska Institutet. Stockholm, Sweden.
Zoé M Cejas GallardoUniversidad Nacional de Córdoba, Facultad de Ciencias Químicas, Departamento de Bioquímica Clínica, Córdoba, Argentina.
Simon C RobsonCenter for Inflammation Research, Department of Anesthesia, Critical Care & Pain Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
Martin RottenbergDepartment of Microbiology, Tumor and Cell Biology, Karolinska Institutet. Stockholm, Sweden.
Maria P AokiUniversidad Nacional de Córdoba, Facultad de Ciencias Químicas, Departamento de Bioquímica Clínica, Córdoba, Argentina.

Funding

Targeting purinergic signaling in Chagas diseaseR01AI176457 · NIAID · NATIONAL RESEARCH COUNCIL OF ARGENTINA · PI Maria Pilar Aoki · 2023 to 2026
$525k
NIAID NIH HHS R01 AI176457
6 · The paper itself

Abstract

Chagas disease, caused by Trypanosoma cruzi, is endemic to Latin America and is characterized by chronic inflammation of cardiac tissues due to parasite persistence. Hypoxia within infected tissues may trigger the stabilization of HIF-1 and be linked to ATP release. Extracellular ATP exhibits microbicidal effects but is scavenged by CD39 and CD73 ectonucleotidases, which ultimately generate adenosine (ADO), a potent immunosuppressor. Here, we comprehensively study the importance of HIF-1 stabilization and the CD39/CD73/ADO axis, on CD4+ T cells with the cytotoxic phenotype, in facilitating the persistence of T. cruzi. Myocardial infection induces prominent areas of hypoxia, which is concomitant with HIF-1α stabilization in T cells and linked to early expansion of CD39+CD73+CD4+ T cell infiltrating population. Functional assays further demonstrate that HIF-1 stabilization and CD73 activity are associated with impaired CD4+ T cell cytotoxic potential. RNA-Seq analysis reveals that HIF-1 and purinergic signaling pathways are overrepresented in cardiac tissues of patients with end-stage Chagas disease. The findings highlight a major effect of purinergic signaling on CD4+ T cells with potential cytotoxic capacity in the setting of T. cruzi infection and have translational implications for therapy.

Indexed as

CD4-Positive T-LymphocytesChagas DiseaseSignal TransductionT-Lymphocytes, CytotoxicTrypanosoma cruzi5'-NucleotidaseAdenosineAdenosine TriphosphateAnimalsAntigens, CDApyraseFemaleGPI-Linked ProteinsHumansHypoxia-Inducible Factor 1, alpha SubunitMale5'-NucleotidaseAdenosineAdenosine TriphosphateAntigens, CDApyraseCD39 antigenENTPD1 protein, humanGPI-Linked ProteinsHIF1A protein, humanHypoxia-Inducible Factor 1, alpha SubunitNT5E protein, humanHypoxiaImmunologyInfectious diseaseInflammationParasitologyT cells

Identifiers

PMID40590226
PMCPMC12208558

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.